Kigali, Rwanda — November 02, 2025 — Bio Usawa congratulates Dr. George Elombi on his new position as President and Board Chair of the African Export-Import Bank (Afreximbank).

Dr. Elombi is highly regarded for his nearly 30 years of service at Afreximbank, where he has played a guiding role in shaping the institution’s legal and governance structures, while strengthening both its capital base as well as its crisis-response activities across Africa and the Caribbean.

His appointment exemplifies Afreximbank’s commitment to both continental and global leadership excellence and strategic vision.

Bio Usawa looks forward to following his continued success as we share the goal of elevating Africa’s continental and global leadership, with a specific lens on making safe, affordable, and high-quality biotherapies more accessible to patients in Africa and beyond. 

About Bio Usawa

Bio Usawa is Africa’s pioneering biotechnology company dedicated to democratizing access to life-saving biotherapeutics. Headquartered in Kigali, Rwanda, the company develops, licenses, and manufactures affordable monoclonal antibodies and biosimilars targeting cancer, diabetes complications, infectious diseases, and autoimmune conditions.